Department of Pharmacology & Chemical Biology at the University of Pittsburgh
Robert Branch, MD
Professor, Medicine
100 Technology Drive
Suite 450, Pittsburgh, PA 15219

Email:
rab13@pitt.edu
Phone: 412-648-7053


Education

BS (Biology), Cheltenham College, UK, 1960.
MD, University of Bristol Medical School, UK, 1965.
Fellow, Royal College of Physicians, UK, 1985.

Photo of Robert Branch, MD

Dr. Branch is a Professor of Medicine and Pharmacology and a nationally and internationally recognized, board certified clinical pharmacologist, whose main research has been on intersubject variability and mechanisms of regulation of drug metabolism in disease states, including liver disease. He is also the Director of the Center for Clinical Pharmacology, and the Program Director of the Montefiore-Clinical and Translational Research Center (MUH-CTRC), one of the 12 sites awarded the Clinical Translational Science Award by NIH/NCRR. Dr. Branch’s research interests and expertise are on the genetic and environmental regulation of drug metabolism, and the pharmacogenetic implications on drug development. His primary research focus has been on the pharmacogenetic contribution to the risk of bladder cancer and hepatic cancer. He continues to develop and expand the pharmacogenomic programs relevant to the etiology of a variety of disease states including Chronic Obstructive Airways Disease and is also actively engaged in research on the mechanisms that influence the selective regulation of drug metabolizing enzymes in aging, obesity, liver disease and pregnancy.





Important Publications
Stewart NA, SC Buch, TP Conrads and RA Branch.  A UPLC-MS/MS assay of the "Pittsburgh cocktail:"  Six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.  Analyst 136:605-612, 2011.
Carr BI, P Pancoska and RA Branch.  Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma:  A large case cohort study.  Hepatol Int 4:396-405, 2010.
Pancoska P, BI Carr and RA Branch.  Network-based analysis of survival for unresectable hepatocellular carcinoma.  Seminars in Oncology 37:170-178, 2010.
Gao W, M Romkes, S Zhong, T Nukui, RA Persad, PJB Smith, R Branch and P Keohavong.  Genetic polymorphisms in the DNA repair genes XPD and XRCCI, p53 gene mutations and bladder cancer risk.  Oncology Reports 24:257-262, 2010.
Branch R and A Chester.  Community-based participatory clinical research in obesity by adolescents:  Pipeline for researchers of the future.  Clin Transl Sci 2:350-354, 2009.




Back to Top